ITRAQ-Based Proteomics Reveals Potential Anti-Virulence Targets for ESBL-Producing
Overview
Authors
Affiliations
Purpose: Treatment of infections with strains producing extended-spectrum beta-lactamases (ESBLs) is challenging due to the coexistence of multiple resistance mechanisms and the hypervirulent variant. Therefore, new targets or more effective treatment options aimed at ESBL-producing are urgently needed.
Materials And Methods: Here, we collected ESBL-producing and non-ESBL isolates and studied their differences from a proteomic point of view.
Results: We revealed treA, wza, gnd, rmlA, rmlC, rmlD, galE, aceE, and sucD as important virulence-related proteins in ESBL-producing , distinct from those in non-ESBL strains.
Conclusion: Our findings provide plausible anti-virulence targets and suggest new therapeutic avenues against ESBL-producing .
Shi J, Yang R, Chen X, Wang Y, Shi Y, Wang Y J Cardiothorac Surg. 2024; 19(1):610.
PMID: 39434140 PMC: 11492498. DOI: 10.1186/s13019-024-03114-x.
Jian M, Lin T, Chung H, Chang C, Perng C, Chang F Infect Drug Resist. 2024; 17:2899-2912.
PMID: 39005853 PMC: 11246630. DOI: 10.2147/IDR.S470821.
Antibiotic Resistance Diagnosis in ESKAPE Pathogens-A Review on Proteomic Perspective.
Kalpana S, Lin W, Wang Y, Fu Y, Lakshmi A, Wang H Diagnostics (Basel). 2023; 13(6).
PMID: 36980322 PMC: 10047325. DOI: 10.3390/diagnostics13061014.
Murray A, Zhang L, Snape J, Gaze W Curr Res Microb Sci. 2023; 4:100184.
PMID: 36908773 PMC: 9995290. DOI: 10.1016/j.crmicr.2023.100184.
Shen C, Shen Y, Zhang H, Xu M, He L, Qie J Front Microbiol. 2021; 12:773829.
PMID: 34867912 PMC: 8637018. DOI: 10.3389/fmicb.2021.773829.